Cortexyme Inc. Stock News

CRTX reported partially promising results on October 26, 2021, which have been perceived as a complete failure by the market.

In the last trading session, 1.34 million shares of the Cortexyme Inc. (NASDAQ:CRTX) were traded. Most recently the companys share price was $11.35, and it changed around -$0.96 or -7.80% from the last close, which brings the market valuation of the company to $353.44M. CRTX currently trades at a discount to its 52-week high of Cortexyme Inc. (NASDAQ: CRTX): The Stock We Should Bet On For Economic Growth In The Months To Come Read More »

Cortexyme Inc. (NASDAQ:CRTX) price closed lower on Friday, December 03, dropping -7.39% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile

Cortexyme (NASDAQ:CRTX) and Allena Pharmaceuticals (NASDAQ:ALNA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, profitability and earnings. Institutional & Insider Ownership 62.7% of Cortexyme shares are held by institutional investors. Comparatively, 27.1% of []

Investors need to pay close attention to Cortexyme (CRTX) stock based on the movements in the options market lately.

Cortexyme Inc. (NASDAQ:CRTX) has seen 1.4 million shares traded in the last trading session. The company, currently valued at $368.55M, closed the last trade at $12.43 per share which meant it gained $0.4 on the day or 3.33% during that session. The CRTX stock price is -881.34% off its 52-week high price of $121.98 and Cortexyme Inc. (CRTX) Slumps 3.33%, A Gain For Bears Read More »

This move is a reversal from the hour prior, which saw price move down. The post Cortexyme Inc (CRTX): Price Now Near $12.69; Daily Chart Shows Downtrend on 50 Day Basis appeared first on ETF Daily News .

Cortexyme Inc. (NASDAQ:CRTX) price on Thursday, November 18, fall -7.86% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $12.90. A look at the stock’s price movement, the close in the last trading session was $14.00, moving within a range at $12.84 and $14.13. The beta value (5-Year … Cortexyme Inc. (NASDAQ:CRTX) Stock Could Be Worth Considering Read More »

Cortexyme Inc. (NASDAQ:CRTX)s traded shares stood at 1.3 million during the last session. At the close of trading, the stocks price was $14.00, to imply a decrease of -4.70% or -$0.69 in intraday trading. The CRTX shares 52-week high remains $121.98, putting it -771.29% down since that peak but still an impressive 11.36% since price Cortexyme Inc. (NASDAQ: CRTX): Can A Stock Be -49.60% Lower Year-To-Date And Still Be A Loser? Read More »

Cortexyme: A Challenging Path Forward

Cortexyme Inc (NASDAQ: CRTX) has presented additional data from its Phase 2/3 GAIN Trial at the Clinical Trials on Alzheimer's Disease Conference.  The 643-participant 48-week GAIN Trial failed t

Cassava Sciences' Simufilam is now seen as the best hope to treat all patients in Alzheimer's disease after disappointment in Cortexyme's data.

Someone with a lot of money to spend (and possibly insider knowledge) has taken a bullish stance on Cortexyme (NASDAQ:CRTX). And retail traders should know.